Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist , representing a potential advance in weight loss . Early study data have demonstrated impressive results, https://elijahdgcm743577.digiblogbox.com/68149741/new-treatment-in-australia-a-promising-breakthrough-for-weight-loss